BeStock  
股票 › 医疗器械 › AXGN

艾索基因 AXGN

美股市值排名 #2491医疗器械
$50.02 +$1.27 (+2.61%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $50.00 -0.04%
开盘$48.55
昨收$48.75
当日区间$48.14 – $50.29
成交量1.67M
市值$2.99B
市盈率(TTM)–
股息率–

基本面

最新报告季度:Q3, ended Sep 2026

营收$75.83M+26.2% YoY
营业利润$955,000.00-50.1% YoY
净利润$2.33M+229.7% YoY
摊薄每股收益$0.04+300.0% YoY
自由现金流$14.87M+995.0% YoY
经营现金流$16.54M

营收,近8个季度

$49.4MDec '24$48.6MMar '25$56.7MJun '25$60.1MSep '25$59.9MDec '25$61.5MMar '26$69.7MJun '26$75.8MSep '26

净利润,近8个季度

$450.0KDec '24$-3.8MMar '25$579.0KJun '25$708.0KSep '25$-13.2MDec '25$-19.6MMar '26$-1.5MJun '26$2.3MSep '26

各季度摊薄每股收益

0.01Dec '24-0.08Mar '250.01Jun '250.01Sep '25-0.28Dec '25-0.38Mar '26-0.03Jun '260.04Sep '26

各季度自由现金流

$7.9MDec '24$-13.8MMar '25$6.6MJun '25$1.4MSep '25$1.1MDec '25$-1.4MMar '26$5.5MJun '26$14.9MSep '26

年度营收

$112.3MFY20$127.4MFY21$138.6MFY22$159.0MFY23$187.3MFY24$225.2MFY25

盈利能力与资产负债表

毛利率74.2%
营业利润率-5.2%
净利率-12.0%
净资产收益率-10.3%
资产收益率-8.3%
投入资本回报率-8.4%
流动比率12.02
负债/资产比率9.9%
现金及投资$348.07M
总负债$17.64M
净现金(净负债)$330.43M
自由现金流/营收7.5%

利润表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
报告营业总收入 $75.83M $69.73M $61.46M $225.21M $59.90M
营业总收入 $75.83M $69.73M $61.46M $225.21M $59.90M
营业成本 $19.10M $19.06M $15.27M $57.86M $15.50M
毛利润 $56.73M $50.67M $46.19M $167.35M $44.41M
营业费用 $55.78M $52.83M $49.02M $175.20M $54.18M
销售及管理费用 $46.83M $44.24M $41.50M $142.32M $41.81M
-销售及营销费用 $30.36M $30.83M $28.63M $97.74M $27.21M
-管理费用 $16.47M $13.41M $12.87M $44.58M $14.59M
研发费用 $8.95M $8.59M $7.52M $32.89M $12.38M
营业利润 $955,000.00 -$2.16M -$2.83M -$7.85M -$9.77M
非经营性利息净收入(支出) -$1,000.00 -$1,000.00 -$694,000.00 -$7.70M -$1.72M
非经营性利息支出 $1,000.00 $1,000.00 $694,000.00 $7.70M $1.72M
其他收入(支出) $1.38M $641,000.00 -$16.06M -$152,000.00 -$1.67M
证券出售收益 $1.43M $786,000.00 $768,000.00 -$319,000.00 -$1.67M
特殊收益(费用) $0.00 $0.00 -$16.85M – –
其他非经营性收入(支出) -$51,000.00 -$145,000.00 $23,000.00 $167,000.00 $0.00
税前利润 $2.33M -$1.52M -$19.58M -$15.70M -$13.16M
净利润 $2.33M -$1.52M -$19.58M -$15.70M -$13.16M
持续经营利润 $2.33M -$1.52M -$19.58M -$15.70M -$13.16M
归属母公司净利润 $2.33M -$1.52M -$19.58M -$15.70M -$13.16M
归属普通股股东净利润 $2.33M -$1.52M -$19.58M -$15.70M -$13.16M
基本每股收益 $0.04 -$0.03 -$0.38 -$0.34 -$0.28
摊薄每股收益 $0.04 -$0.03 -$0.38 -$0.34 -$0.28
每股股息 $0.00 $0.00 $0.00 $0.00 $0.00
-减:其他特殊支出 – – $16.85M – –

资产负债表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
总资产 $550.34M $304.86M $289.49M $221.69M $221.69M
流动资产合计 $438.09M $200.38M $184.71M $120.42M $120.42M
现金及现金等价物与短期投资 $348.07M $111.41M $101.60M $41.53M $41.53M
-现金及现金等价物 $328.89M $94.57M $82.65M $35.55M $35.55M
-短期投资 $19.18M $16.84M $18.95M $5.98M $5.98M
应收款 $34.01M $34.13M $28.31M $26.17M $26.17M
-应收账款 $34.01M $34.13M $28.31M $26.17M $26.17M
存货 $49.06M $47.31M $46.07M $42.37M $42.37M
受限现金 $2.00M $2.00M $2.00M $4.00M $4.00M
其他流动资产 $4.95M $5.53M $6.72M $6.35M $6.35M
非流动资产合计 $112.25M $104.49M $104.78M $101.27M $101.27M
固定资产净值 $95.34M $96.19M $97.32M $94.52M $94.52M
-固定资产原值 $124.90M $124.18M $125.35M $120.95M $120.95M
-累计折旧 -$29.56M -$28.00M -$28.03M -$26.43M -$26.43M
商誉及其他无形资产 $7.91M $7.57M $7.27M $6.75M $6.75M
-其他无形资产 $7.91M $7.57M $7.27M $6.75M $6.75M
其他非流动资产 $9.00M $729,000.00 $192,000.00 – –
负债合计 $54.24M $48.61M $44.68M $92.84M $92.84M
流动负债合计 $36.46M $30.37M $26.01M $23.56M $23.56M
短期债务及融资租赁负债 $1.83M $1.98M $2.12M $2.37M $2.37M
-一年内到期融资租赁负债 $1.83M $1.98M $2.12M $2.37M $2.37M
非流动负债合计 $17.78M $18.23M $18.67M $69.28M $69.28M
长期债务及融资租赁负债 $17.64M $18.09M $18.53M $65.26M $65.26M
-长期融资租赁负债 $17.64M $18.09M $18.53M $16.87M $16.87M
衍生产品负债 $0.00 $0.00 $0.00 $3.89M $3.89M
其他非流动负债 $141,000.00 $141,000.00 $140,000.00 $141,000.00 $141,000.00
股东权益合计 $496.10M $256.26M $244.81M $128.85M $128.85M
股东权益 $496.10M $256.26M $244.81M $128.85M $128.85M
股本 $597,000.00 $537,000.00 $532,000.00 $472,000.00 $472,000.00
-普通股 $597,000.00 $537,000.00 $532,000.00 $472,000.00 $472,000.00
资本公积 $821.24M $583.78M $570.82M $435.34M $435.34M
留存收益 -$325.73M -$328.06M -$326.55M -$306.96M -$306.96M
应付款 – – – $2.89M $2.89M
-应付账款 – – – $2.89M $2.89M
一年内应计费用 – – – $1.67M $1.67M
-长期债务 – – – $48.39M $48.39M

现金流量表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
经营活动现金流 $16.54M $7.22M $1.57M $812,000.00 $3.04M
持续经营经营活动现金流净额 $16.54M $7.22M $1.57M $812,000.00 $3.04M
持续经营净利润 $2.33M -$1.52M -$19.58M -$15.70M -$13.16M
持续经营损益 -$62,000.00 -$136,000.00 $16.88M $1.16M $1.93M
折旧、折耗与摊销 $2.14M $2.15M $2.13M $8.51M $2.97M
其他非现金项目 $0.00 $0.00 $68,000.00 $891,000.00 $225,000.00
营运资金变动 $3.27M -$2.11M -$4.65M -$24.61M -$5.63M
-应收款变动 $62,000.00 -$5.88M -$2.02M -$2.46M $4.56M
-存货变动 -$1.75M -$1.24M -$3.70M -$9.19M -$1.79M
-预付资产变动 $572,000.00 $1.20M -$368,000.00 -$3.91M -$3.29M
-应付账款及应计费用变动 $6.24M $4.92M $2.20M -$7.16M -$4.17M
-其他流动资产变动 -$1.26M -$537,000.00 -$192,000.00 – –
-其他流动负债变动 -$594,000.00 -$570,000.00 -$560,000.00 -$1.89M -$946,000.00
投资活动现金流净额 -$10.93M $500,000.00 -$15.96M -$5.32M $4.04M
持续经营投资活动现金流净额 -$10.93M $500,000.00 -$15.96M -$5.32M $4.04M
固定资产购置及出售净额 -$1.39M -$893,000.00 -$2.79M -$3.75M -$1.25M
无形资产购置及出售净额 -$274,000.00 -$857,000.00 -$175,000.00 -$1.85M -$711,000.00
投资购置及出售净额 -$9.27M $2.25M -$13.00M $277,000.00 $6.00M
筹资活动现金流 $228.71M $4.20M $59.51M $10.50M $4.57M
持续经营筹资活动现金流净额 $228.71M $4.20M $59.51M $10.50M $4.57M
债务发行及偿还净额 -$5,000.00 -$2,000.00 -$48.59M -$32,000.00 -$21,000.00
普通股发行净额 $225.58M $0.00 $134.04M – –
股票期权行使所得 $3.86M $4.70M $4.23M $10.53M $4.59M
其他筹资费用净额 -$723,000.00 -$497,000.00 -$30.17M – –
期末现金余额 $330.89M $96.57M $84.65M $39.55M $39.55M
现金净变动 $234.32M $11.92M $45.11M $5.99M $11.65M
期初现金余额 $96.57M $84.65M $39.55M $33.55M $27.90M
自由现金流 $14.87M $5.47M -$1.40M -$4.78M $1.08M

讨论区

暂无评论——快来第一个聊聊 AXGN。

登录后参与讨论。

Scroll to Top